Drug Topics May 22, 2024
A report from Dexcom found that depression and anxiety are commonly reported in patients living with type 2 diabetes, but continuous glucose monitors can make disease management easier.
A new report that surveyed patients with type 2 diabetes (T2D) and their caregivers found that living with the disease negatively impacts mental health, Dexcom announced in a release.1 The survey also found that continuous glucose monitors (CGM) make it easier to manage T2D and having access to the technology would have a positive impact.
The “State of Type 2 Report” from Dexcom was conducted in collaboration with market research company Censuswide. The survey included 250 patients living with T2D and 250 caregivers, such as family members. Over 350 health care professionals...